Luskin A, Griffin NM, Wagele-Steffen A, et al. Decreased exacerbations and hospitalizations in adolescents enrolled in PROSPERO (Prospective Observational Study to Evaluate Predictors of Clinical Effectiveness in Response to Omalizumab). ATS 2017, abstract A5104.
Nirsevimab voorkomt RSV bij gezonde laat-premature en voldragen zuigelingen
mrt 2022 | Virale infecties